Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
| Treatment | Cmax (mg/L) | AUC (mg.h/L) |
|---|---|---|
| Tacrolimus | 0.025 (0.011) | 0.0296 (0.11) |
| Tacrolimus + Anidulafungin | 0.024 (0.008) | 0.0289 (0.08) |